Schedule 13G ownership disclosure

TETRAPHASE PHARMACEUTICALS INC

Security class unavailable · CUSIP: 88165N105

Event date: 2015-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,896,987
Percent of class
13.4500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-15-000576
Form type
SC 13G/A
Filer
TETRAPHASE PHARMACEUTICALS INC
CIK
CIK 1373707
Filed
Oct 13, 2015
Reporting period
Sep 30, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub